878 related articles for article (PubMed ID: 10722599)
1. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.
Ulett GC; Ketheesan N; Hirst RG
Infect Immun; 2000 Apr; 68(4):2034-42. PubMed ID: 10722599
[TBL] [Abstract][Full Text] [Related]
2. The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection.
Koo GC; Gan YH
BMC Immunol; 2006 Aug; 7():19. PubMed ID: 16919160
[TBL] [Abstract][Full Text] [Related]
3. Analogous cytokine responses to Burkholderia pseudomallei strains contrasting in virulence correlate with partial cross-protection in immunized mice.
Ulett GC; Ketheesan N; Clair TW; McElnea CL; Barnes JL; Hirst RG
Infect Immun; 2002 Jul; 70(7):3953-8. PubMed ID: 12065542
[TBL] [Abstract][Full Text] [Related]
4. Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.
Barnes JL; Ulett GC; Ketheesan N; Clair T; Summers PM; Hirst RG
Immunol Cell Biol; 2001 Oct; 79(5):490-501. PubMed ID: 11564157
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory cytokine mRNA responses in experimental Burkholderia pseudomallei infection in mice.
Ulett GC; Ketheesan N; Hirst RG
Acta Trop; 2000 Feb; 74(2-3):229-34. PubMed ID: 10674654
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei.
Amemiya K; Dankmeyer JL; Bearss JJ; Zeng X; Stonier SW; Soffler C; Cote CK; Welkos SL; Fetterer DP; Chance TB; Trevino SR; Worsham PL; Waag DM
BMC Immunol; 2020 Feb; 21(1):5. PubMed ID: 32013893
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.
Müller A; Schott-Ohly P; Dohle C; Gleichmann H
Immunobiology; 2002 Mar; 205(1):35-50. PubMed ID: 11999343
[TBL] [Abstract][Full Text] [Related]
8. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei.
Easton A; Haque A; Chu K; Lukaszewski R; Bancroft GJ
J Infect Dis; 2007 Jan; 195(1):99-107. PubMed ID: 17152013
[TBL] [Abstract][Full Text] [Related]
9. Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infection.
Breitbach K; Wongprompitak P; Steinmetz I
BMC Immunol; 2011 Mar; 12():20. PubMed ID: 21410970
[TBL] [Abstract][Full Text] [Related]
10. T cell cytokine synthesis at the single-cell level in BALB/c and C57BL/6 mice infected with ectromelia virus.
Szulc L; Gieryńska M; Winnicka A; Martyniszyn L; Boratyńska-Jasińska A; Niemiałtowski M
Postepy Hig Med Dosw (Online); 2012 Apr; 66():222-30. PubMed ID: 22706108
[TBL] [Abstract][Full Text] [Related]
11. Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection.
Haque A; Easton A; Smith D; O'Garra A; Van Rooijen N; Lertmemongkolchai G; Titball RW; Bancroft GJ
J Infect Dis; 2006 Feb; 193(3):370-9. PubMed ID: 16388484
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.
Giese NA; Gazzinelli RT; Actor JK; Morawetz RA; Sarzotti M; Morse HC
Immunology; 1996 Mar; 87(3):467-74. PubMed ID: 8778035
[TBL] [Abstract][Full Text] [Related]
13. Impaired early cytokine responses at the site of infection in a murine model of type 2 diabetes and melioidosis comorbidity.
Hodgson KA; Govan BL; Walduck AK; Ketheesan N; Morris JL
Infect Immun; 2013 Feb; 81(2):470-7. PubMed ID: 23208607
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3β inhibition improved survivability of mice infected with Burkholderia pseudomallei.
Tay TF; Maheran M; Too SL; Hasidah MS; Ismail G; Embi N
Trop Biomed; 2012 Dec; 29(4):551-67. PubMed ID: 23202600
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection.
Mohrs M; Holscher C; Brombacher F
Infect Immun; 2000 Apr; 68(4):1773-80. PubMed ID: 10722563
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.
Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK
Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility to Burkholderia pseudomallei is associated with host immune responses involving tumor necrosis factor receptor-1 (TNFR1) and TNF receptor-2 (TNFR2).
Barnes JL; Williams NL; Ketheesan N
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):379-88. PubMed ID: 18294191
[TBL] [Abstract][Full Text] [Related]
18. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
[TBL] [Abstract][Full Text] [Related]
19. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
20. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.
Liu B; Koo GC; Yap EH; Chua KL; Gan YH
Infect Immun; 2002 Feb; 70(2):504-11. PubMed ID: 11796576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
